Loading…
Loading…
[url="]PGIM[/url],1 the $1.4 trillion global asset management business of Prudential Financial, Inc. ([url="]NYSE: PRU[/url]) announces that the previously dis
NEWARK, N.J.--(BUSINESS WIRE)--This restatement is the result of an accounting error in calculating each exchange-traded fund's NAV by a third-party administrator.
PGIM Active Aggregate Bond ETF (NYSEARCA:PAB - Get Free Report) was the recipient of a large growth in short interest during the month of April. As of April 15th, there was short interest totaling 4,810 shares, a growth of 354.2% from the March 31st total of 1,059 shares. Based on an average daily volume of
Intrua Financial LLC grew its holdings in shares of PGIM Active Aggregate Bond ETF (NYSEARCA:PAB) by 18.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 129,756 shares of the company's stock after purchasing an additional 20,537 shares during the quarter.
D.A. Davidson and CO. lifted its holdings in SPDR Portfolio Aggregate Bond ETF (NYSEARCA:SPAB) by 5.4% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 10,381 shares of the company's stock after buying an additional 534 shares during the quarter. D.A. Davidson
Investors continued to plow money into taxable (+$32.0 billion) and tax-exempt (+$4.8 billion) bond funds (including ETFs) for the month of September. For the month, the average taxable and tax-exempt fixed income mutual fund posted a 0.48% and 0.75% decline, respectively, for September and are up 0.50% and 1.27% so far this year.
MELBOURNE--(BUSINESS WIRE)---- $PAB #antibody--Patrys Limited (ASX:PAB), a therapeutic antibody development company, has announced the publication of preclinical data for its therapeutic antibody candidate PAT-DX1 in The Journal of Clinical Investigation—Insight. Patrys is developing PAT-DX1 for use in DDR-deficient cancers, including a range of primary brain cancers and metastases. PAT-DX1 is a cell-penetrating autoantibody that localizes into live cell nuclei, inhibits DNA repair, and is synthetically lethal to
On Thursday, PGIM Investments expanded its ETF lineup with the launch of the PGIM Active Aggregate Bond ETF (NYSE Arca: PAB). PAB is an actively managed fixed income ETF seeking total return through a combination of current income and capital appreciation.